Hecht Peter M 4
4 · Cyclerion Therapeutics, Inc. · Filed May 6, 2021
Insider Transaction Report
Form 4
Hecht Peter M
Director10% Owner
Transactions
- Purchase
Common Stock
2021-05-04$2.29/sh+300,000$687,000→ 524,527 total - Purchase
Common Stock
2021-05-05$2.53/sh+398,001$1,006,943→ 922,528 total
Holdings
- 485(indirect: By Trust)
Common Stock
- 485(indirect: By Trust)
Common Stock
- 485(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.10 to $2.45, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
- [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.32 to $2.61, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
- [F3]These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.